# EDGAR Filing Document

**Accession Number:** 0000927066
**File Stem:** 0000927066-25-000107
**Filing Date:** 2025-6
**Character Count:** 6930
**Document Hash:** 4cc86774e5a5c1325b8ec4303a20c019
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000927066-25-000107.hdr.sgml**: 20250609

**ACCESSION NUMBER**: 0000927066-25-000107

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 12

**CONFORMED PERIOD OF REPORT**: 20250605

**ITEM INFORMATION**: Submission of Matters to a Vote of Security Holders

**FILED AS OF DATE**: 20250609

**DATE AS OF CHANGE**: 20250609

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** DAVITA INC.
- **CENTRAL INDEX KEY:** 0000927066
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 510354549
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-14106
- **FILM NUMBER:** 251034553

**BUSINESS ADDRESS:**
- **STREET 1:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202
- **BUSINESS PHONE:** 310-536-2668

**MAIL ADDRESS:**
- **STREET 1:** 2000 16TH STREET
- **CITY:** DENVER
- **STATE:** CO
- **ZIP:** 80202

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAVITA HEALTHCARE PARTNERS INC.
- **DATE OF NAME CHANGE:** 20121107

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** DAVITA INC
- **DATE OF NAME CHANGE:** 20001005

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** TOTAL RENAL CARE HOLDINGS INC
- **DATE OF NAME CHANGE:** 19950524

?xml version='1.0' encoding='ASCII'? dva-20250605

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

**Form 8-K** 

**CURRENT REPORT** 

**Pursuant to Section 13 or 15(d) of the** 

**Securities Exchange Act of 1934** 

**Date of Report (date of earliest event reported): June 5, 2025** 

**DAVITA INC.** 

**(Exact name of registrant as specified in its charter)** 

---

| | | |
|:---|:---|:---|
| **DE** | **1-14106** | **51-0354549** |
| **(State or other jurisdiction<br>of incorporation)** | **(Commission File Number)** | **(IRS Employer<br>Identification No.)** |

---

---

| | | |
|:---|:---|:---|
| **2000 16th Street** | **2000 16th Street** | **2000 16th Street** |
| **Denver,** | **CO** | **80202** |

---

 **(Address of principal executive offices including Zip Code)** 

**(720) 631-2100** 

 **(Registrant's telephone number, including area code)** 

**Not applicable** 

**(Former name or former address, if changed since last report)** 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **Title of each class:** | **Trading symbol(s):** | **Name of each exchange on which registered:** |
| **Common Stock, $0.001 par value** | **DVA** | **New York Stock Exchange** |

---

------

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

☐&nbsp;&nbsp;&nbsp;&nbsp;Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

------

**Item 5.07.&nbsp;&nbsp;&nbsp;&nbsp;Submission of Matters to a Vote of Security Holders.**

On June 5, 2025, DaVita Inc. (the "Company") held its virtual 2025 Annual Meeting of Stockholders (the "Annual Meeting"). Represented virtually or by proxy at the Annual Meeting were 69,548,287 shares of the Company's common stock, or approximately 90% of its outstanding shares of common stock as of April 9, 2025, the record date of the Annual Meeting. The proposals presented at the Annual Meeting are described in detail in the Company's Definitive Proxy Statement on Schedule 14A filed with the Securities and Exchange Commission on April 24, 2025. The vote results detailed below represent final results as certified by the Inspector of Elections.

***Proposal 1. Election of Directors.***

The Company's stockholders elected the nine director nominees named below to the Company's Board of Directors for a term expiring at the 2026 Annual Meeting of Stockholders or until their respective successors are duly elected and qualified. The voting results are as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Name of Nominee** | **For** | **Against** | **Abstain** | **Broker non-votes** |
| Pamela M. Arway | 61548822 | 1542308 | 23621 | 6433536 |
| Barbara J. Desoer | 62068583 | 1022592 | 23576 | 6433536 |
| Jason M. Hollar | 62380680 | 708429 | 25642 | 6433536 |
| Gregory J. Moore, MD, PhD | 63031224 | 58184 | 25343 | 6433536 |
| Dennis W. Pullin | 63035553 | 23750 | 55448 | 6433536 |
| Javier J. Rodriguez | 63066381 | 21984 | 26386 | 6433536 |
| Adam H. Schechter | 62872915 | 217127 | 24709 | 6433536 |
| Wendy L. Schoppert | 62867043 | 223104 | 24604 | 6433536 |
| Phyllis R. Yale | 62900167 | 191031 | 23553 | 6433536 |

---

***Proposal 2. Ratification of the appointment of KPMG LLP as the Company's independent registered public accounting firm.***

The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2025. The voting results are as follows:

---

| | | |
|:---|:---|:---|
| **For** | **Against** | **Abstain** |
| 66,500,682 | 3,022,683 | 24,922 |

---

***Proposal 3. Advisory vote to approve named executive officer compensation.***

The Company's stockholders approved, on an advisory basis, the compensation of the Company's named executive officers. The voting results are as follows:

---

| | | | |
|:---|:---|:---|:---|
| **For** | **Against** | **Abstain** | **Broker non-votes** |
| 59,322,425 | 3,527,754 | 264,572 | 6,433,536 |

---

------

**SIGNATURES** 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

---

| | | |
|:---|:---|:---|
| | DAVITA INC. | DAVITA INC. |
| Date: June 9, 2025 | By: | /s/ Samantha Caldwell |
|  |  | Samantha Caldwell |
|  |  | Corporate Secretary |

---